Patrick A. Mayes - 21 Jul 2025 Form 3 Insider Report for INCYTE CORP (INCY)

Reporting relationship: EVP & Chief Scientific Officer
Issuer ticker: INCY
Reported as of: 21 Jul 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 05 Aug 2025, 16:03:49 UTC
Next SEC filing: 03 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Feeney, Attorney-In-Fact

Filing notes and source

Key filing fact

Patrick A. Mayes filed Form 3 for INCYTE CORP (INCY) on 05 Aug 2025.

Key facts

This page summarizes Patrick A. Mayes's Form 3 filing for INCYTE CORP (INCY).
0 reported transactions and 16 derivative rows are listed below.
Accepted by SEC: 05 Aug 2025, 16:03.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002079962 Primary reporting owner

Mayes Patrick A

Relationship: EVP & Chief Scientific Officer
Address: 1801 AUGUSTINE CUT-OFF, WILMINGTON
Signature: /s/ Elizabeth Feeney, Attorney-In-Fact
Signature date: 05 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INCY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 67,388
Date: 21 Jul 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,381
Exercise price: $105.43
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,148
Exercise price: $68.62
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,459
Exercise price: $72.27
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,642
Exercise price: $85.01
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,643
Exercise price: $80.50
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,292
Exercise price: $106.47
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,293
Exercise price: $90.56
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,263
Exercise price: $83.58
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,623
Exercise price: $74.78
Footnotes: F2

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,055
Exercise price: $77.67
Footnotes: F3

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,225
Exercise price: $83.20
Footnotes: F4

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,942
Exercise price: $61.76
Footnotes: F5

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,246
Exercise price: $61.18
Footnotes: F6

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,222
Exercise price: $64.25
Footnotes: F7

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,737
Exercise price: $71.93
Footnotes: F8

INCY holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 21 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,846
Exercise price: $68.25
Footnotes: F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

This includes: 3,533 restricted stock units ("RSUs") granted on October 1, 2021 that will vest fully on October 1, 2025; 1,128 RSUs granted on July 2, 2022 that will fully on July 2, 2026; 3,079 RSUs granted on January 20, 2023 that will vest fully on January 20, 2027; 2,820 RSUs granted on July 14, 2023 that will vest 1,140 on July 14, 2026 and July 14, 2027; 5,253 RSUs granted on July 15, 2024 that will vest 1,751 on July 15, 2026, July 15, 2027 and July 15, 2028; 39,783 RSUs granted on June 6, 2025 that will vest fully on June 6, 2028; and 7,795 RSUs granted on July 15, 2025 that will vest 25% annually over four years.

Footnote F2

As of July 21st, 2025, the award is fully vested and exercisable

Footnote F3

Options granted on July 2, 2022 and will vest monthly through July 2, 2026

Footnote F4

Options granted on January 20, 2023 and will vest monthly through July 2, 2026

Footnote F5

Options granted on July 14, 2023 and will vest monthly through July 14, 2027

Footnote F6

Options granted on January 18, 2024 and will vest monthly through July 14, 2027

Footnote F7

Options granted on July 15, 2024 and will vest monthly through July 15, 2028

Footnote F8

Options granted on January 17, 2025 and will vest monthly through July 15, 2028

Footnote F9

Options granted on July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .